The purpose of this study is to evaluate the efficacy and safety of KW-3357 compared to
plasma-derived antithrombin using multi-center, open-label, parallel-group, comparative
method in patients with Disseminated Intravascular Coagulation (DIC) associated with
infection.
Phase:
Phase 3
Details
Lead Sponsor:
Kyowa Hakko Kirin Company, Limited Kyowa Kirin Co., Ltd.